These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes. Soto-Pedre E, Hernaez-Ortega MC, Piniés JA. Ophthalmic Epidemiol; 2007; 14(2):76-9. PubMed ID: 17464854 [Abstract] [Full Text] [Related]
27. Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: a 10-year observation study. Lövestam-Adrian M, Hansson-Lundblad C, Torffvit O. Diabetes Res Clin Pract; 2007 Jul; 77(1):141-7. PubMed ID: 17178168 [Abstract] [Full Text] [Related]
33. Early detection of changes in visual function in diabetes mellitus. Ismail GM, Whitaker D. Ophthalmic Physiol Opt; 1998 Jan; 18(1):3-12. PubMed ID: 9666905 [Abstract] [Full Text] [Related]
34. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Shimura M, Yasuda K, Shiono T. Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970 [Abstract] [Full Text] [Related]
39. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Murgatroyd H, Ellingford A, Cox A, Binnie M, Ellis JD, MacEwen CJ, Leese GP. Br J Ophthalmol; 2004 Jul; 88(7):920-4. PubMed ID: 15205238 [Abstract] [Full Text] [Related]
40. Topographical distribution of retinal and optic disc neovascularization in early stages of proliferative diabetic retinopathy. Jansson RW, Frøystein T, Krohn J. Invest Ophthalmol Vis Sci; 2012 Dec 17; 53(13):8246-52. PubMed ID: 23169887 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]